Skip to main content
. 2019 Apr 30;11(5):606. doi: 10.3390/cancers11050606

Figure 2.

Figure 2

Kaplan-Meier estimates of progression-free survival (a) and overall survival (b) among patient with resectable PC treated with the neoadyuvant approach.